InvestorsHub Logo
Followers 135
Posts 13916
Boards Moderated 0
Alias Born 09/05/2013

Re: I-Glow post# 127784

Thursday, 07/03/2014 8:53:07 PM

Thursday, July 03, 2014 8:53:07 PM

Post# of 137704
The problem with GW is in its core. There are at best questionable values behind taking a chemical from its naturally phyto-reactive state and making it more expensive and less effective. Then they serve it in an alcohol base which dries and irritates the mouths of cancer patients who then get sores form the over dryness that the alcohol causes. Then consider GW completely ignoring the well documented "entourage effect" by singling out one cannabinoid so that it cannot synergistically work with the others as it was designed. GW either don't get it or don't care that their product is an over-processed American cheese to be prescribed by doctors who have never read a paragraph about the endocannabinoid system or how it requires a whole web of inter and intra cannabinoid events (some degenerate into others) in order to be balanced. The UK/GW is trying to get even with us for McDonalds. Hemp derived products (less than .3% THC) are classified as dietary supplements by the FDA. The legislative blunders are the state CBD laws that are arising. CBD is not included in the federal CSA as it only refers to cannabinols but not cannabinoids. CBD is a cannabinoid but not a cannabinol. There is a difference. I hope Rikki Lakes new documentary that is being crowdfunded on indiegogo.com will clear up some of Dr. Guptas misguidance. MJN* has been shipping CBD all over the U.S. and the rest of the world for a year now. Why did Sanjay mention patent 6630507 but not mention the fact that the NIH exclusively licensed Phytosphere (MJN*/CAN*) for the commercialization of that patent? He then moved from the patent on to GW who just happened to get a nice contact with Cuomo and NY. Food for Thought.